← Open Payments lookup

KAREN SCHALLER: Open Payments

NPI 1518208172 · BETHLEHEM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,579 in 92 payments from 19 companies in 2025. Trend: 2023 $2,621 · 2024 $2,405 · 2025 $2,579

Food & beverage: $2,418Education: $161
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP28$695
Regeneron Healthcare Solutions, Inc.9$283
GlaxoSmithKline, LLC.8$265
Ionis Pharmaceuticals, Inc.5$244
CSL Behring7$199
Takeda Pharmaceuticals U.S.A., Inc.8$196
BioCryst US Sales Co., LLC5$124
GENZYME CORPORATION4$111
SANOFI-AVENTIS U.S. LLC1$89
Verona Pharma, Inc.2$56

Products named: DUPIXENT, FASENRA, NUCALA, DAWNZERA, AIRSUPRA, TEZSPIRE, Haegarda, ORLADEYO.

Industry payments across PA — which companies pay providers there.